Cargando…
Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders
Psychiatric disorders impose tremendous economic burden on society and are leading causes of disability worldwide. However, only limited drugs are available for psychiatric disorders and the efficacy of most currently used drugs is poor for many patients. To identify novel therapeutic targets for ps...
Autores principales: | Liu, Jiewei, Cheng, Yuqi, Li, Ming, Zhang, Zhijun, Li, Tao, Luo, Xiong-Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483418/ https://www.ncbi.nlm.nih.gov/pubmed/36114287 http://dx.doi.org/10.1038/s41386-022-01456-5 |
Ejemplares similares
-
Proteome‐Wide Mendelian Randomization Analysis Identified Potential Drug Targets for Atrial Fibrillation
por: Wang, Xinpei, et al.
Publicado: (2023) -
Calcium Homeostasis and Psychiatric Disorders: A Mendelian Randomization Study
por: Jiang, Miaomiao, et al.
Publicado: (2023) -
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19
por: Gaziano, Liam, et al.
Publicado: (2021) -
Transcriptome-wide association study identifies new susceptibility genes and pathways for depression
por: Li, Xiaoyan, et al.
Publicado: (2021) -
Phosphodiesterase and psychiatric disorders: a two-sample Mendelian randomization study
por: Jiang, Miaomiao, et al.
Publicado: (2023)